TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Rhea-AI Summary

TransMedics (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy solutions, announced its participation in the Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on Tuesday, August 12, 2025, at 11:30 a.m. ET at the InterContinental Boston Hotel.

Investors can access both the live and archived webcast of the fireside chat, along with the company's standard investor presentation, through the "Investors" section of TransMedics' website at investors.transmedics.com.

News Market Reaction

+2.74% 2.2x vol

42 alerts

+2.74% News Effect

+7.2% Peak in 3 hr 52 min

+$97M Valuation Impact

$3.64B Market Cap

2.2x Rel. Volume

On the day this news was published, TMDX gained 2.74%, reflecting a moderate positive market reaction. Argus tracked a peak move of +7.2% during that session. Our momentum scanner triggered 42 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $97M to the company's valuation, bringing the market cap to $3.64B at that time. Trading volume was elevated at 2.2x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

ANDOVER, Mass., July 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming Canaccord Genuity 45^th Annual Growth Conference at the InterContinental Boston Hotel. Management is scheduled to present on Tuesday, August 12, 2025, at 11:30 a.m. Eastern Standard Time.

Event: Canaccord Genuity 45^th Annual Growth Conference
Date: Tuesday, August 12, 2025
Time: 11:30 a.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-canaccord-genuity-45th-annual-growth-conference-302516215.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics (TMDX) presenting at the Canaccord Genuity Conference 2025?

TransMedics will present on Tuesday, August 12, 2025, at 11:30 a.m. Eastern Standard Time at the InterContinental Boston Hotel.

How can investors watch TransMedics' (TMDX) Canaccord conference presentation?

Investors can access the live and archived webcast of the fireside chat through the 'Investors' section of TransMedics' website at investors.transmedics.com.

What does TransMedics (TMDX) specialize in?

TransMedics is a medical technology company that develops organ transplant therapy solutions for patients with end-stage lung, heart, and liver failure.

Where is the Canaccord Genuity Growth Conference 2025 being held?

The conference is being held at the InterContinental Boston Hotel in Boston.